Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease

Aim. To study the specific clinical features in patients with coronary heart disease, CHD (stable effort angina, SEA) and chronic obstructive pulmonary disease (COPD), in order to improve early diagnostics of this combined pathology. Material and methods. The study was a retrospective analysis of 95...

Full description

Bibliographic Details
Main Authors:	A. N. Kuznetsov, N. Yu. Grigoryeva, E. G. Sharabrinv
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	хроническая обструктивная болезнь легких ишемическая болезнь сердца стабильная стенокардия одышка
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1806

Similar Items

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)

Coronary artery status in patients with coronary heart disease and chronic obstructive pulmonary disease: results of selective coronary angiography
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)

Causes of shortness of breath in patients with stable coronary heart disease
by: S. F. Yarmedova, et al.
Published: (2022-10-01)

FORECASTING CORONARY EVENTS BASED ON THE ANALYSIS OF THE DYNAMICS OF MORPHOFUNCTIONAL PARAMETERS OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE NORTH
by: D. A. Dolgopolova, et al.
Published: (2018-02-01)

The influence of catalaza gene polymorphism on the development of cardiovascular pathology in chronic obstructive pulmonary disease
by: T A Uklistaya, et al.
Published: (2012-12-01)

Dynamics of characteristics of respiratory function for the development of coronary heart disease in patients with chronic obstructive lung disease
by: D. A. Vishnyak, et al.
Published: (2019-03-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

Nitrates in complex angina management during the age of aggressive coronary atherosclerosis treatment
by: D. M. Aronov, et al.
Published: (2005-10-01)

Кардиореспираторные послеоперационные осложнения у пациентов с ишемической болезнью сердца после планового коронарного шунтирования: связь с функцией легких
by: E. V. Bazdyrev, et al.
Published: (2017-07-01)

Subpopulations of blood monocytes in patients with generalized hypoxia
by: S. P. Chumakova, et al.
Published: (2019-05-01)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DEFINITION, EPIDEMIOLOGY, PATHOPHYSIOLOGY, CLINICAL PICTURE AND TREATMENT (GOLD 2013)
by: M. T. Vatutin, et al.
Published: (2015-12-01)

Study of Heart Rate Variability in Patients with Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
by: M. E. Statsenko, et al.
Published: (2021-08-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

Клинические особенности хронической обструктивной болезни легких у пожилых людей.
by: Nicolae BODRUG, et al.
Published: (2021-11-01)

COVID-19 and chronic obstructive pulmonary disease: what is known about the unknown
by: E. S. Ovsyannikov, et al.
Published: (2021-03-01)

The chronic obcructive pulmonary disease in military veterans: problems and perspectives
by: G I Gurko
Published: (2010-12-01)

Various protocols of extracorporeal shock wave therapy in the treatment of stable angina
by: M. M. Shcherbak, et al.
Published: (2019-11-01)

Predictors of long term adverse events after scheduled endovascular coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-08-01)

ROLE OF SYSTEMATIC INFLAMMATION IN THE DEVELOPMENT OF COMORBIDITY IN CASE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2017-06-01)

Psychogenic dyspnea and hypocapnia in men with ischemic heart disease before and after CABG
by: O. V. Grishin, et al.
Published: (2018-06-01)

MODERN VIEW OF CARDIOPULMONARY EXERCISE TESTING (REVIEW OF ACR/EULAR GUIDELINES, 2016)
by: N. T. Vatutin, et al.
Published: (2017-03-01)

Eosinophils as a non-invasive marker to assess inflammatory activities in those suffering from chronic obstructive pulmonary disease
by: M. A. Kаrnаushkinа, et al.
Published: (2018-11-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Functional State of Respiratory Muscles in Patients with Chronic Obstructive Pulmonary Disease
by: I. G. Kurpаtov, et al.
Published: (2021-07-01)

Approaches to the diagnosis, treatment and prevention of exacerbations of chronic obstructive pulmonary disease. According to the materials of the Congress «Chelovek I lekarstvo» and the Summit of pulmonologists-2019
by: Yu. V. Evsyutina
Published: (2019-12-01)

Rational pharmacotherapy of chronic obstructive pulmonary disease in elderly patients with cardiac arrhythmias: the role of a betaadrenoblocker bisoprolol
by: D. A. Kadaeva, et al.
Published: (2010-10-01)

Self-management of the disease and its role in preventing exacerbations in chronic obstructive pulmonary disease
by: L. V. Kukol, et al.
Published: (2020-03-01)

COMPLEX APPROACHES TO TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH ISHEMIC HEART DISEASE
by: M. A. Chichkova, et al.
Published: (2015-10-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

Outside of easy display of chronic obstructive pulmonary disease: clinical and functional-morphological aspects of changes of intestines
by: E. I. Beloborodova, et al.
Published: (2009-08-01)

Clinico-angiographic parallels in patients with coronary atherosclerosis risk factors
by: A. I. Koryakov
Published: (2006-06-01)

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

Systemic cytokine potential in patients with chronic obstructive pulmonary disease who completed treatment for pulmonary tuberculosis
by: A. A. Khrenov, et al.
Published: (2020-02-01)

EARLY DETECTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE — VECTOR ON BIOMARKERS
by: V. I. Shevcova, et al.
Published: (2016-08-01)

THE ROLE OF MICROBIAL COMMUNITIES OF AIRWAYS IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: S. V. Fedosenko, et al.
Published: (2014-02-01)

COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS
by: N. A. Karoli, et al.
Published: (2016-01-01)

Methodological aspects of the study of the pharmaceutical care to patients of chronic obstructive pulmonary disease
by: N O Karabintseva, et al.
Published: (2013-12-01)

The content of hypoxia-inducible factors and mediators of immunosuppression in the blood in diseases associated with hypoxia
by: S. P. Chumakova, et al.
Published: (2020-10-01)